Company: NCEL
Filing Date: 2025-02-10
Form Type: F-3
Source: 0001213900-25-011823
Chunk: 35

Company: NewcelX Ltd.
Filing Date: 2025-02-10
Form: F-3
Chunk 35
---
 make payments to the National Insurance Institute, which is similar
to the U.S. Social Security Administration. Kadimastem’s employees have defined benefit pension plans that comply with applicable
Israeli legal requirements, which also include the mandatory pension payments required by applicable law and allocations for severance
pay.

While none of Kadimastem’s
employees are party to any collective bargaining agreements, certain provisions of the collective bargaining agreements between the Histadrut
(General Federation of Labor in Israel) and the Coordination Bureau of Economic Organizations (including the Industrialists’ Associations)
are applicable to Kadimastem’s employees by extension orders issued by the Israel Ministry of Economy (previously the Israeli Ministry
of Trade, Industry and Labor). These provisions primarily concern the length of the workweek, pension fund benefits for all employees
and for employees in the industry section, insurance for work-related accidents, travel expenses reimbursement, holiday leave, convalescent
payments and entitlement for vacation days. Kadimastem generally provide Kadimastem’s employees with benefits and working conditions
beyond the required minimums. Kadimastem has never experienced any employment-related work stoppages and believe Kadimastem’s relationship
with Kadimastem’s employees is good.

All of Kadimastem’s
employment and consulting agreements include employees’ and consultants’ undertakings with respect to non-competition and
assignment to Kadimastem of intellectual property rights developed in the course of employment and confidentiality. The enforceability
of such provisions is limited by Israeli law.

Company Information

Kadimastem was established
as an Israeli company on October 6, 2008. Kadimastem began trading on the Tel Aviv Stock Exchange in June 2013.

<div align='center'>30

RISK FACTORS</div>

Investing in our securities involves significant
risks. Before making an investment decision, you should carefully consider the risks below and those described under “Risk Factors”
in the applicable prospectus supplement and under Item 3.D. - “Risk Factors” in our most recent Annual Report on Form 20-F,
or any updates in our Reports on Form 6-K, together with all of the other information appearing in this prospectus or incorporated by
reference into this prospectus and any applicable prospectus supplement, in light of your particular investment objectives and financial
circumstances. The risks so described are not the only risks facing us. Additional risks not presently known to us or that we currently